Clinical Trial: Post-hoc analysis of Myopia progression after discontinuation of Atropine sulfate (DE-127) ophthalmic solution in the Phase II/III clinical trial in Japan (Japan)

Tokyo, Aug. 5 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058693) titled 'Post-hoc analysis of Myopia progression after discontinuation of Atropine sulfate (DE-127) ophthalmic solution in the Phase II/III clinical trial in Japan' on Aug. 4.

Study Type: Others,meta-analysis etc

Primary Sponsor: Institute - Santen Pharmaceutical Co., Ltd.

Condition: Condition - Myopia Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - Using data of subjects that continued to treatment period II in Atropine sulfate (DE-127) ophthalmic solution in the Phase II/III clinical trial in Japan, we will examine the changes in cycloplegic objective spherical equivalent...